News
Asianet Newsable on MSN43m
Retail Traders Pile Into Ionis As Wall Street Hikes Price Targets On FDA Approval Of Swelling Disorder Therapy
BofA Securities raised its target to $64 with a ‘Buy’ rating, while Stifel lifted its target to $43 with a ‘Hold,’ both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback